Canada, Central & South America

Top Navigation - Canada

News
Events
Careers
Investors
Compliance

Healthcare Professionals
Patients & Caregivers
- Atrial Fibrillation
- Cryo Nerve Block
About AtriCure

Canada, Central & South America

Isolator Synergy EnCompass Clamp Now Available

The Isolator Synergy EnCompass Clamp is the newest addition to the Synergy Ablation Clamp family and is now available in Canada

Learn More

Top Workplaces 2025

Ready to work at a Top Workplace?

Learn About Opportunities

Providing Several Months of Post-Op Pain Relief

Cryo Nerve Block Therapy uses a unique freezing method to temporarily block pain signals from the nerves.

Learn More

0

Patients Served with Ablation Worldwide

0

AtriClip Devices Sold Worldwide

NEWS

AtriCure Reports First Quarter 2026 Financial Results

READ THE RELEASE

REDUCING GLOBAL AFIB

What is Afib, and how does it affect heart performance?

LEARN ABOUT AFIB

CAREERS

Interested in joining our mission to reduce the global Afib epidemic?

SEARCH AVAILABLE OPPORTUNITIES

CLINICAL EVIDENCE

Learn about active clinical trials and trials with results

EXPLORE CLINICAL EVIDENCE

LinkedIn
YouTube
Facebook

AtriCure, Inc. @AtriCure.• 05.08.2026

Women with Afib are often diagnosed later than men and may present with different symptom patterns—factors that can influence timing and treatment pathways. Recognizing these differences is key to improving timely identification and optimizing outcomes in Afib management. Learn more: https://okt.to/ZY6jUJ #WomensHealthWeek #NationalWomensHealthWeek

JUMP TO POST

AtriCure, Inc. @AtriCure.• 05.08.2026

The left atrial appendage (LAA) is more than a source of stroke risk—it can also contribute to the abnormal electrical activity that sustains Afib. Durable LAA exclusion with electrical isolation may help support rhythm stabilization and a return to sinus rhythm as part of a more complete treatment strategy. Comprehensive Afib care means managing the LAA. Explore why electrically isolating the LAA matters in Afib: https://okt.to/LWmJ8h #LAAExclusion #Afib

JUMP TO POST

AtriCure, Inc. @AtriCure.• 05.06.2026

Stroke risk remains one of the most serious consequences of untreated Afib. During Stroke Awareness Month, it’s a reminder that addressing Afib during cardiac surgery through approaches like surgical ablation and left atrial appendage management can play a meaningful role in reducing stroke risk and supporting long-term outcomes. Treat the rhythm. Help change the trajectory. Learn more about restoring sinus rhythm: https://okt.to/n3V6dQ #StrokeAwarenessMonth #StrokeAwareness #Afib

JUMP TO POST

AtriCure, Inc. @AtriCure.• 05.06.2026

In the ICE-AFIB Trial, patients who received concomitant Cox-Maze III lesions using the cryoICE cryoFORM® Cryoablation probe during cardiac surgery experienced improvements in quality of life.* Mean QoL scores* improved by +32 points at 12 and 24 months compared to baseline – demonstrating durable benefit over time. Read the full study: https://okt.to/qlLImZ *As calculated from the Atrial Fibrillation Effect on Quality of Life (AFEQT) questionnaire. A 5-point change is considered clinically meaningful.

JUMP TO POST

How to Talk to Patients About the Correlation Between Afib and Heart Failure

Duration: 00:43

JUMP TO POST

Afib and Heart Failure

Duration: 00:34

JUMP TO POST

Screening for Afib

Duration: 00:25

JUMP TO POST

Structural Abnormalities in Cardiac Patients

Duration: 00:41

JUMP TO POST

AtriCure, Inc. @AtriCure.• 8 May 2026

1 in 3 people having cardiac surgery already have Afib. Afib is a common heart rhythm condition that can increase the risk of stroke and other complications—but many people don’t even realize they have it. Learn more about Afib symptoms and when to talk to your doctor at: https://okt.to/XfTDs0 #Afib #AtrialFibrillation #AfibAwareness

JUMP TO POST

AtriCure, Inc. @AtriCure.• 6 May 2026

Cardiovascular disease is the leading cause of death among women, but the American Heart Association is working to change that. AtriCure is proud to support the AHA and their ongoing efforts in heart health research, education, and community programs, including the Heart Walk, CycleNation, Heart Ball, and the recent Go Red for Women Experience in Cincinnati. #AHA #AmericanHeartAssociation

JUMP TO POST

AtriCure, Inc. @AtriCure.• 1 May 2026

As we recognize Military Appreciation Month, we extend our gratitude to all who have served and continue to serve our country with courage and dedication. Your sacrifice in protecting our freedoms is deeply valued and truly inspiring. Today and every day, we honor our military heroes and their families for their selflessness and bravery. Thank you for your service. #MilitaryAppreciationMonth

JUMP TO POST

AtriCure, Inc. @AtriCure.• 30 Apr 2026

Joseph faced a below‑the‑knee amputation to stop a life‑threatening infection. During surgery, his surgeon used Cryo Nerve Block Therapy to help manage the post‑operative pain. Joseph says that with less pain, he’s accomplished many of the goals he had set for himself. Learn more: https://okt.to/aQTUpE #LLLDAM #Amputation

JUMP TO POST

05.08.2026, AtriCure, Inc. @AtriCure

The LAA is more than a source of stroke risk—it can also contribute to the electrical activity that sustains Afib. Durable LAA exclusion with electrical isolation may help support rhythm stabilization and a return to sinus rhythm as part of a more complete strategy.

JUMP TO POST

05.06.2026, AtriCure, Inc. @AtriCure

Stroke risk remains a consequence of untreated Afib. During Stroke Awareness Month, addressing Afib during cardiac surgery—through surgical ablation and LAA management—may help reduce stroke risk and improve long-term outcomes. Treat the rhythm. Change the trajectory. Learn more:

JUMP TO POST

05.06.2026, AtriCure, Inc. @AtriCure

In the ICE-AFIB Trial, patients who received concomitant Cox-Maze III lesions using the cryoICE cryoFORM® Cryoablation probe during cardiac surgery experienced improvements in quality of life.*

JUMP TO POST

05.05.2026, AtriCure, Inc. @AtriCure

Another quarter, another step forward. Our Q1 results highlight the impact of our strategy in action. Read the full earnings report: https://t.co/NIzAWdN4fk #Earnings #FinancialResults

JUMP TO POST

Sorry, something went wrong.

If refreshing the content doesn’t work, you can check out our other
social media channels to keep updated on the latest at AtriCure.

Therapies and Procedures

AtriCure offers a robust portfolio of products used in some of the most complex therapies and procedures.

Explore Now

PM-CANLAM-2654B-0427-G

About AtriCure

Overview
News
Careers
Investors
Leadership
Board of Directors
Locations

More Information

Contact Us
Compliance
Statement Against Modern Slavery
Terms of Use
Privacy Notice
Site Map

Healthcare Professionals
Patients & Caregivers
- Atrial Fibrillation
- Cryo Nerve Block
About AtriCure

More Information Compliance UK Slavery Act Terms of Use Privacy Notice Site Map

The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.

Click "Agree" to confirm you are a Healthcare Professional.

The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.

Click "Agree" to confirm you are a Healthcare Professional.

The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.

Click "Agree" to confirm you are a Patient or a Caregiver.

You are leaving the AtriCure Asia Pacific site

You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.

You are leaving the AtriCure Asia Pacific site

You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.

You are leaving the AtriCure Asia Pacific site

You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.

You are leaving the AtriCure Europe & Middle East site

You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.

You are leaving the AtriCure Europe & Middle East site

You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.

You are leaving the AtriCure Europe & Middle East site

You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.

You are leaving the AtriCure Canada, Central & South America site

You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.

You are leaving the AtriCure Canada, Central & South America site

You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.

You are leaving the AtriCure Canada, Central & South America site

You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.